Get notified when PAHC files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: PAHC PHIBRO ANIMAL HEALTH CORP 8-K

Phibro appoints Daniel Bendheim CEO with $850K salary, 300K performance RSUs tied to $70-$100 stock targets

Filed June 26, 2026 · Period ending June 25, 2026 · ~1 min read

Key Changes

  • high

    Daniel Bendheim appointed CEO and President effective July 1, 2026, with $850K base salary, 50% target bonus, and annual RSU grants targeted at 50% of base salary.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • high

    Bendheim granted 300K performance RSUs vesting June 30, 2031, based on 90-day average stock price: 25% vest at $70, 100% at $100+, with linear interpolation between; zero vest below $70.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • medium

    All unvested RSUs immediately vest at 100% if company delists following change of control or if CEO terminated without cause within 12 months of control change.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (BNC 10-K) is open in full — no account needed.

Partner

Trade PAHC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 29, 2026 12:15 AM